Studies on how combinations of drugs (like TKIs and anti-CTLA-4) treat sarcoma, particularly Alveolar Soft Part Sarcoma.
This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors. 13569.rar
If you can specify whether you are looking for or genetic sequencing data from this file, I can provide more precise information. Studies on how combinations of drugs (like TKIs